Genomics

Dataset Information

TP53 signature predicts survival outcome in triple-negative breast cancer with neoadjuvant chemotherapy


ABSTRACT: TP53 signature predicts survival outcome in triple-negative breast cancer with neoadjuvant chemotherapy

PROVIDER: PRJNA786568 | ENA |

REPOSITORIES: ENA